相关实验视频

Updated: Jan 15, 2026

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

神经表皮生长因子-1 (NELL-1) 相关的膜性病:来自第三级护理中心的临床和基于结果的研究

Muzamil Ahmad Wani¹, Shahnawaz Hassan¹, Amir Farooq¹

¹Nephrology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, IND.

|October 14, 2025

概括

神经表皮生长因子类1 (NELL-1) 相关的膜性病 (MN) 呈现为主要或次要病例. 识别毒素或恶性瘤等触发因素是关键,大多数患者通过治疗和支持性护理实现缓解.

科学领域:

腎臟病學 (nephrology) 是一種醫學專業.
免疫学免疫学免疫学
病理学病理学病理学

背景情况:

膜性病 (MN) 是成年人性综合征的主要原因.
神经表皮生长因子类型1 (NELL-1) 是一种新发现的向抗原,用于MN病例的一个子集.
了解NELL-1相关的MN对于诊断和管理至关重要.

研究的目的:

为了评估NELL-1-相关的MN的临床特征.
为了确定二次原因和关联.
评估治疗策略和患者的治疗结果.

主要方法:

在2022年1月至2024年4月期间诊断的MN患者的回顾性观察性研究.
包括通过脏活检免疫组织化学确认的NELL-1-阳性MN患者.
分析临床数据,二次原因,治疗方法和结果,包括缓解,蛋白尿和血清白蛋白水平.

主要成果:

18.5%的MN患者 (12/65) 患有NELL-1相关的MN,平均年龄为34岁,66.7%为女性.
二次原因包括暴露于 (25%),恶性瘤 (16.7%) 和牛皮 (8.3%);50%的人患有初级的MN.
蛋白尿和血清白蛋白显著改善,66.7%的患者实现了完全缓解,25%的患者实现了部分缓解.

结论:

与NELL-1相关的MN是一种异质的疾病,具有初级和二级形式.
识别和解决诸如毒性暴露或恶性瘤等诱发因素对于缓解至关重要.
大多数患者通过支持性护理和/或免疫抑制获得缓解,但由于潜在的复发,需要长期监测.

关键词:

成年人瘤综合征的发生.淋巴细胞疾病淋巴细胞疾病脏疾病脏疾病膜性脏病是一种脏病.在Nell-1抗原.

更多相关视频

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

Isolation of Glomeruli and In Vivo Labeling of Glomerular Cell Surface Proteins

Isolation of Glomeruli and In Vivo Labeling of Glomerular Cell Surface Proteins

Published on: January 18, 2019

相关概念视频

Nephrotic Syndrome III : Nursing Management

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...

Nephrotic Syndrome II : Assessment and Medical Management

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...